Physician

Ahmed Zaghloul Soliman, M.D.

According to 2025 Medicare claims, Ahmed Soliman, M.D. (NPI: 1669795316) practices ophthalmology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is LANSING OPHTHALMOLOGY, P.C. (NPI: 1962485342; TIN: 381818892) and primary practice location at 48823-1378.

Soliman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 1,179 HCPCS/CPT codes, and received $129,966 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,677 prescription claims across 723 beneficiaries totaling $141,183 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 2 records totaling $250. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $105,137 and ending at $129,966. Concurrently, Part D prescription costs have risen steadily, from $4,814 to $141,183. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$65K$130K2017 Medicare payment: $105,137 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $119,850 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $124,056 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $82,596 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $108,201 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $55,864 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $110,953 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $129,966 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20174171,222$105,137
20184101,293$119,850
20193721,164$124,056
2020225696$82,596
2021252952$108,201
2022226617$55,864
20233531,001$110,953
20244421,179$129,966

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$71K$141K2015 Drug cost: $4,814 (USD; Tot_Drug_Cst)2016 Drug cost: $1,125 (USD; Tot_Drug_Cst)2017 Drug cost: $13,841 (USD; Tot_Drug_Cst)2018 Drug cost: $86,477 (USD; Tot_Drug_Cst)2019 Drug cost: $114,759 (USD; Tot_Drug_Cst)2020 Drug cost: $88,901 (USD; Tot_Drug_Cst)2021 Drug cost: $88,566 (USD; Tot_Drug_Cst)2022 Drug cost: $73,236 (USD; Tot_Drug_Cst)2023 Drug cost: $77,342 (USD; Tot_Drug_Cst)2024 Drug cost: $141,183 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151945$4,814
2016N/R26$1,125
2017116204$13,841
20183741,028$86,477
20194611,425$114,759
20203511,075$88,901
20213311,015$88,566
2022266810$73,236
2023431922$77,342
20247231,677$141,183

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens83126$377
92014Established patient complete exam of visual system6060$81
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more123129$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more231357$60
92136Measurement of corneal curvature and depth of eye115169$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine191,470$29,309
FluorometholoneFluorometholone2039,151$18,160
Tobramycin-DexamethasoneTobramycin/Dexamethasone38210,977$16,124
CyclosporineCyclosporine161,320$9,752
Prednisolone AcetatePrednisolone Acetate1689,944$8,182

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$250Ellex, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Zaghloul Soliman, M.D.?

Tedicare shows public-source Medicare data for Ahmed Zaghloul Soliman, M.D. (NPI 1669795316), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Zaghloul Soliman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed Zaghloul Soliman, M.D.?

Ahmed Zaghloul Soliman, M.D. is linked to LANSING OPHTHALMOLOGY, P.C. (billing NPI 1962485342) in the available physician profile data.

Does Ahmed Zaghloul Soliman, M.D. have Open Payments data?

Ahmed Zaghloul Soliman, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.